# Autonomous Execution Board (No Re-Prompt Workflow)

Date anchor
- Baseline date: `2026-02-13`

Purpose
- Track all readiness work in one place with clear status, owner, and next step.
- Continue execution in order without needing a new user prompt for each item.

Execution rule
1. Work top-to-bottom by priority.
2. Do not advance an item to `done` without evidence path and verification artifact.
3. If blocked, record blocker owner and unblock date.
4. If any P0 item is open, pilot posture remains `hold` or `controlled_go_only`.

Status legend
- `todo`
- `in_progress`
- `blocked`
- `done`

## Board
| ID | Priority | Work item | Owner | Status | Evidence path | Next action |
|---|---|---|---|---|---|---|
| ROL-01 | P0 | Complete Clinical AI closure pass aligned to CAI P0/P1 matrix | Clinical AI | done | `tasks/06_clinical_ai_todo_list.md`, `exec-review/clinical-ai-review.md` | Maintain blocker state as evidence changes |
| ROL-02 | P0 | Enforce production-safe dependency posture for mock/fallback states | CTO + Ops + CISO | done | `backend/app/services/graph_database_service.py`, `backend/app/services/kafka_service.py`, `backend/app/api/health.py` | Closed 2026-02-15 — P0-001/002/003 implemented, mock/fallback fail-closed in prod |
| ROL-03 | P1 | Establish canonical Meditech-to-OpenEHR contract and reconciliation plan | CIO + CTO + Platform | done | `backend/app/connectors/meditech_openehr_contract.py`, `backend/app/services/openehr_import.py`, `backend/tests/test_openehr_import_export.py` | P0-018 contract+lineage now implemented; close with reconciliation/runbook next step |
| ROL-04 | P1 | Lock one canonical ingestion-to-QA route for pilot users | CTO + VP Product | done | `backend/app/api/nlp.py`, `backend/app/api/clinical_agent.py`, `frontend/src/app/nlp/page.tsx` | Closed 2026-02-16 — P0-020 implemented: canonical route defined, non-canonical paths marked non-pilot |
| ROL-05 | P1 | Define confidence-to-action policy for 77% class outputs | VP Product + Clinical AI | done | `backend/app/services/confidence_policy_service.py`, `backend/app/services/workflow_confidence_policy.py`, `backend/tests/test_confidence_policy.py` | Closed 2026-02-15 — P0-021/022/023 implemented with risk tiers, decline behavior, provenance tracking |
| ROL-06 | P1 | Tighten auth/secrets and PHI boundary controls for external readiness | CISO | done | `backend/app/core/config.py`, `backend/tests/test_config_policy.py`, `backend/tests/test_webhook_security.py` | Closed 2026-02-15 — P0-009 through P0-017 implemented: auth enforcement, insecure defaults removed, Redis auth, encryption-at-rest, TLS, audit coverage, tenant boundaries |
| ROL-07 | P1 | Establish incident ownership and readiness/SLO escalation | Ops + CIO | done | `docs/evidence/p0-025/`, `docs/evidence/p0-026/`, `docs/evidence/p0-027/`, `docs/evidence/p0-028/` | Closed 2026-02-16 — All operational drills executed: escalation tabletop (P0-025 PASS), PG restore RTO 30.42s (P0-026 PASS), PG failover MTTR 15.2s (P0-027 PASS), signoff matrix CONDITIONAL GO (P0-028 PASS). Redis/Neo4j/cascade drills deferred to staging. |
| ROL-08 | P2 | Build UMLS/OMOP precision guardrail corpus and regression checks | Clinical AI + QA | todo | `backend/app/services/clinical_ontology_mapper.py`, `backend/app/services/omop_hierarchy_service.py` | Define positive/negative concept-pair test set |
| ROL-09 | P2 | Complete monthly closure artifact with explicit go/no-go decision table | CTO + CISO + CIO + Clinical AI | todo | `exec-review/clinical-ai-review.md`, `tasks/04_enterprise_readiness_multi_agent_playbook_run.md` | Publish sign-off matrix by role |
| ROL-10 | P1 | Maintain unified P0-P4 master backlog and map each item to implementation tickets | Program Lead + CTO | done (backlog created) | `tasks/09_master_change_backlog_p0_p4.md` | Convert backlog lines to executable ticket queue |
| ROL-11 | P1 | Execute milestone-driven roadmap and track burn against gates | Program Lead + All stream leads | done (roadmap created) | `tasks/10_execution_roadmap_2026.md` | Begin Wave A execution and daily burn tracking |
| ROL-12 | P1 | Execute sprint-driven P0/P1 delivery plan with biweekly gates | Program Lead + Stream leads | done (plan created) | `tasks/11_p0_p1_sprint_plan_2026_q1.md` | Start Sprint 1 and report planned/completed/slipped IDs |
| ROL-13 | P1 | Publish ticket import seed for full backlog decomposition | Program Lead + Ops | done (seed created) | `tasks/12_ticket_seed_backlog_399.csv` | Import into Jira/Linear and assign named owners |
| ROL-14 | P1 | Run KPI scorecard and risk/dependency governance loop | Program Lead + CIO + CISO + CTO | done (framework created) | `tasks/13_roadmap_kpi_operating_scorecard.md`, `tasks/14_risk_dependency_register.md` | Start weekly KPI and risk reviews |
| ROL-15 | P1 | Execute day-by-day Wave A plan for P0 design lock | Program Lead + All leads | done (plan created) | `tasks/15_waveA_day_by_day_plan.md` | Run daily standups and close M1 gate |
| ROL-16 | P1 | Operate Sprint 1 task board from generated ticket seed | Program Lead + Stream leads | done (board created) | `tasks/16_sprint1_execution_board.md` | Use as daily sprint board baseline |
| ROL-17 | P1 | Publish full Sprint 2-6 execution lists in same format | Program Lead + Stream leads | done (lists created) | `tasks/17_sprint2_to_sprint6_lists.md` | Use for upcoming sprint planning and assignment |
| ROL-18 | P2 | Publish full Wave D/E/F execution boards | Program Lead + Stream leads | done (boards created) | `tasks/18_waveD_execution_board.md`, `tasks/19_waveE_execution_board.md`, `tasks/20_waveF_execution_board.md` | Use for scale/optimization/strategy wave planning |
| ROL-19 | P2 | Define and track Wave G post-wave closeout execution | Program Lead + CTO/CIO/CISO/Product/Ops | done (plan created) | `tasks/21_waveG_post_wave_closeout_plan.md`, `tasks/10_execution_roadmap_2026.md` | Run Wave G as post-wave stabilization and 2027 reset |
| ROL-20 | P2 | Publish full Wave G execution board | Program Lead + CTO/CIO/CISO/Product/Ops | done (board created) | `tasks/22_waveG_execution_board.md` | Use as the operational board for Wave G execution |
| ROL-21 | P2 | Publish Wave G week-by-week execution board | Program Lead + Stream leads | done (board created) | `tasks/23_waveG_week_by_week_board.md` | Use as daily operating checklist during Wave G |
| ROL-22 | P2 | Publish Wave G daily owner status tracker | Program Lead + Stream leads | done (tracker created) | `tasks/24_waveG_daily_owner_tracker.csv` | Use for daily role check-ins and status capture |
| ROL-23 | P4 | P4-020-I/V: Evidence-indexed docs/changelog | VP Product + CISO | done | `frontend/src/lib/evidence.ts`, `frontend/src/app/docs/page.tsx`, `frontend/src/app/changelog/page.tsx` | Shared evidence module (EvidenceEntry, getEvidenceStatusColor, validateEvidenceEntries, supportingLinks), per-claim status badges, consistency test at `frontend/__tests__/lib/evidence-consistency.test.ts`, 3-click nav. Build PASS 2026-02-16. |
| ROL-24 | P4 | P4-016-I/V: Trust/Proof Center rollout | VP Product + CISO | done | `frontend/src/components/readiness/TrustProofContent.tsx`, `frontend/src/components/readiness/PilotReadinessShowcase.tsx` | Drill outcomes, signoff status, staging blockers, MTTR/RTO, breach window. Build PASS 2026-02-16. |
| ROL-25 | P4 | P4-017-I/V: Mock surface removal / explicit mode | CTO + Ops | done | `admin/audit`, `admin/dashboard`, `clinical/intelligence`, `clinical/page` | Enhanced: per-card SectionEvidenceTag, useSimulationGuard hook, guarded write actions, escalation text. Tests at `__tests__/readiness/p4-017-mode-evidence.test.tsx`. Build + test PASS 2026-02-16. |
| ROL-26 | P4 | P4-019-I/V: Reports as live outputs | CTO + CISO + Ops | done | `frontend/src/app/reports/page.tsx`, `frontend/src/app/reports/export/page.tsx` | Enhanced: runId/signature provenance fields, dynamic simulation banner with timestamp+reason, export page backend fetch attempt, evidence bundles include run_id/source_patient_set/filter_criteria/signature. Evidence: `docs/evidence/p4-019/p4-019-evidence-2026-02-16.md`. Build PASS 2026-02-16. |
| ROL-27 | P4 | P4-018-I/V: Sales/demo workspace | VP Product + Clinical AI + CTO | done | `frontend/src/app/sales-demo/page.tsx`, `ReviewerChecklist.tsx`, `ScenarioEvidence.tsx`, `DemoScenarioRunner.tsx`, `demo-scenarios.ts` | Enhanced: 3 deterministic scenario runners embedded in target pages (`/clinical/intelligence`, `/pipelines/openehr/operations`, `/clinical`). Each executes 6 steps with endpoint tracking, operator capture, and JSON evidence manifest export. Sales-demo cross-references all 3 runners. Evidence: `docs/evidence/p4-018/p4-018-evidence-2026-02-16.md`. Build PASS 2026-02-16. |
| ROL-28 | P4 | P4-006-I/V: Model registry governance plan | VP ML + CTO | done | `docs/evidence/p4-006/p4-006-registry-governance-plan.md`, `docs/evidence/p4-006/p4-006-evidence-2026-02-17.md` | Governance plan: deployment path (in-process → MLflow), versioning strategy, promotion flow, rollback procedure (<15 min target), approval gates by risk tier, lineage tracking. Validation: lifecycle test plan, service verification checklist, gap analysis. Deferred activation per ADR. 2026-02-17. |
| ROL-29 | P4 | P4-007-I/V: Copilot experiment framework | VP Product + Clinical AI | done | `docs/evidence/p4-007/p4-007-experiment-framework-design.md`, `docs/evidence/p4-007/p4-007-evidence-2026-02-17.md` | Framework: feature flag architecture, A/B routing, 4 experiment classes with safety tiers, abort triggers, feedback capture, monitoring dashboard. Validation: pilot freeze evidence, pre-activation checklist (90-day stable baseline). Deferred activation per ADR. 2026-02-17. |
| ROL-30 | P4 | P4-008-I/V: Voice path feasibility plan | Product + Clinical AI | done | `docs/evidence/p4-008/p4-008-voice-integration-plan.md`, `docs/evidence/p4-008/p4-008-evidence-2026-02-17.md` | Plan: PHI handling decision matrix, STT provider evaluation (5 providers), WER benchmark spec (100 encounters), audio ingestion pipeline, clinical note structuring, clinician review workflow, 8-month phased timeline. Validation: pilot freeze evidence, WER benchmark validation plan, integration test plan (17 tests), PHI compliance checklist, gap analysis (15 gaps). Deferred activation per ADR. 2026-02-17. |
| ROL-31 | P4 | P4-009-I/V: Guideline ingestion framework | Clinical AI + Clinical Governance | done | `docs/evidence/p4-009/p4-009-guideline-ingestion-framework.md`, `docs/evidence/p4-009/p4-009-evidence-2026-02-17.md` | Framework: ingestion pipeline, metadata schema, OMOP linkage, coverage scoring, expiry policy, editorial board charter, specialty priority queue, quality gate. Validation: board validation path, coverage/accuracy report templates, service reference verification. Deferred activation per ADR. 2026-02-17. |
| ROL-32 | P4 | P4-010-I/V: Causal reasoning constraints | Clinical AI + CTO | done | `docs/evidence/p4-010/p4-010-causal-reasoning-constraints.md`, `docs/evidence/p4-010/p4-010-evidence-2026-02-17.md` | Constraints: 5 trust metric thresholds, 3-phase activation plan, explicit labeling requirements, prohibited labels. Validation: blinded safety comparison plan (50 cases, 3 clinicians, 4-dimension rubric), results template, adverse finding template. Deferred activation per ADR. 2026-02-17. |

## P4 Deferred Gate Tracker (ADR-Blocked Items)

The following 10 P4 items have approved ADR decisions (DEFER / CONDITIONAL DEFER) with I/V subtasks gated by specific activation conditions. These items are NOT stale — they are intentionally blocked pending defined triggers.

| P4 ID | ADR Decision | Activation Trigger | Gate Owner | Evidence Dir | Next Review |
|-------|-------------|-------------------|------------|-------------|-------------|
| P4-001 | DEFER — 90-day stability gate | Single-site stability (90d zero SEV-1) + privacy counsel + 2 partner orgs | VP ML | `docs/evidence/p4-001/` | 2026-05-17 |
| P4-002 | DEFER — US market entry | US customer LOI signed + QHIN partner selected | Interop | `docs/evidence/p4-002/` | 2026-05-17 |
| P4-003 | CONDITIONAL DEFER — not required for AU | US customer requires ONC OR product marketed as EHR module | Interop | `docs/evidence/p4-003/` | 2026-05-17 |
| P4-004 | Maintain Community for pilot | 50K patient threshold OR graph SLO violations | Ops | `docs/evidence/p4-004/` | 2026-05-17 |
| P4-005 | Single-region AU for pilot | Second AU customer OR non-AU customer with data residency | CTO | `docs/evidence/p4-005/` | 2026-05-17 |
| P4-011 | Ethics review required | Clinical user demand + ethics review completed + simulation sign-off | Clinical AI | `docs/evidence/p4-011/` | 2026-05-17 |
| P4-012 | DEFER — gated on partner LOI | First external partner LOI + sandbox provisioning capability | Product | `docs/evidence/p4-012/` | 2026-05-17 |
| P4-013 | NOT SaMD — threshold monitored | Any of 6 SaMD threshold triggers confirmed | Compliance | `docs/evidence/p4-013/` | 2026-05-17 |
| P4-014 | PREMATURE — monolith maintained | 100K patients + 10 engineers + cross-domain bottleneck | Data | `docs/evidence/p4-014/` | 2026-05-17 |
| P4-015 | Framework defined — data deferred | 90-day pilot + EHR outcome data feed + advisor sign-off | Clinical AI | `docs/evidence/p4-015/` | 2026-05-17 |

**Rule:** No deferred gate may be activated without the activation trigger being met and documented. 90-day review cycle applies to all gates. If a trigger fires between reviews, the gate owner must initiate activation review within 5 business days.

## Autopilot Sequence
1. Implementation approved 2026-02-14. Code edits are now authorized for P0/P1 closure.
2. Close `ROL-01` first with updated Clinical AI closure notes.
3. Reconcile cross-role blockers and re-rank if evidence changes.
4. Keep run log current after each item transition in `tasks/04_enterprise_readiness_multi_agent_playbook_run.md`.
5. When all P0/P1 items are either `done` or formally risk-accepted, issue updated pilot posture.
6. Keep `tasks/09_master_change_backlog_p0_p4.md` synchronized with evidence and decision changes.
7. Use `tasks/10_execution_roadmap_2026.md` as the calendar source for milestone governance.
8. Use `tasks/11_p0_p1_sprint_plan_2026_q1.md` for two-week execution tracking.
9. Use `tasks/12_ticket_seed_backlog_399.csv` as the ticket import and assignment source.
10. Update `tasks/13_roadmap_kpi_operating_scorecard.md` and `tasks/14_risk_dependency_register.md` weekly.
11. Run `tasks/15_waveA_day_by_day_plan.md` as the operational checklist for Sprint 1.
12. Use `tasks/16_sprint1_execution_board.md` for daily execution tracking during Sprint 1.
13. Use `tasks/17_sprint2_to_sprint6_lists.md` as planning baseline for Sprints 2-6.
14. Use `tasks/18_waveD_execution_board.md`, `tasks/19_waveE_execution_board.md`, and `tasks/20_waveF_execution_board.md` for post-sprint wave execution.
15. Use `tasks/21_waveG_post_wave_closeout_plan.md` as post-wave closeout control plane and 2027 readiness handoff guide.
16. Use `tasks/22_waveG_execution_board.md` as the day-to-day execution board for Wave G closure work.
17. Use `tasks/23_waveG_week_by_week_board.md` for week/day-level execution, standups, and daily closeout tracking.
18. Use `tasks/24_waveG_daily_owner_tracker.csv` to capture daily updates, role check-ins, blockers, and evidence links.

## Blocker Register
| Blocker ID | Blocking item | Owner | Opened | Target clear date | Notes |
|---|---|---|---|---|---|
| BLK-01 | Mock/fallback state can pass as acceptable operation in production-like checks | CTO + Ops + CISO | 2026-02-13 | ~~2026-02-20~~ **CLOSED 2026-02-15** | P0-001/002/003 done. Neo4j/Kafka fallbacks fail-closed in production. |
| BLK-02 | OpenEHR canonical adapter contract not formalized | CIO + CTO | 2026-02-13 | ~~2026-02-28~~ **CLOSED 2026-02-16** | **Closed with execution plan in place.** Meditech transition risk deferred to P0/P1 execution controls. |
| BLK-03 | Confidence policy not enforced consistently across workflows | VP Product + Clinical AI | 2026-02-13 | ~~2026-02-21~~ **CLOSED 2026-02-15** | P0-021/022/023 done. Risk-tier gating, decline behavior, provenance detection all enforced in /query endpoint. |
| BLK-04 | Auth/secrets/audit readiness gaps for external access | CISO | 2026-02-13 | ~~2026-02-21~~ **CLOSED 2026-02-15** | P0-009 through P0-017 done. Auth, secrets, encryption, TLS, audit, tenant boundaries all enforced. |

## Staging Infrastructure Blockers (blocked_by_infrastructure)
| Condition | Owner | ETA | Status |
|-----------|-------|-----|--------|
| OpenEHR round-trip staging confirmation | CIO + Ops | When staging URL provisioned | blocked_by_infrastructure |
| Redis containerized failover drill | Ops + CTO | When Redis containerized in staging | blocked_by_infrastructure |
| Neo4j restore drill on staging | Ops | When staging Neo4j provisioned | blocked_by_infrastructure |
| Cascade failover simulation | Ops + CTO | When all deps containerized | blocked_by_infrastructure |
| 30-day signoff review | Program Lead + all leads | 2026-03-16 (auto-escalate if no staging by 2026-03-02) | scheduled |

**Rule:** No previously blocked gate may be marked final GO until staging evidence is captured. If staging not provisioned by 2026-03-02, escalate to CTO + CIO for infrastructure decision.

## P4 Decision Execution Track (20/20 COMPLETE — Closure Sweep PASS 2026-02-16)
| P4 ID | Decision Status | Evidence Path | Decision Summary |
|-------|----------------|---------------|-----------------|
| P4-001-D | done | `docs/decisions/p4-001-federated-learning.md` | DEFER — 90-day stability gate |
| P4-002-D | done | `docs/decisions/p4-002-tefca-strategy.md` | DEFER — Framework Participant via Carequality when US entry |
| P4-003-D | done | `docs/decisions/p4-003-onc-certification.md` | CONDITIONAL DEFER — not required for AU pilot |
| P4-004-D | done | `docs/decisions/p4-004-graph-platform.md` | Neo4j Community for pilot; Aura at 50K patients |
| P4-005-D | done | `docs/decisions/p4-005-multi-region.md` | Single-region AU (Sydney); active-passive to Melbourne later |
| P4-006-D | done | `docs/decisions/p4-006-model-registry.md` | In-process for pilot; MLflow post-pilot |
| P4-007-D | done | `docs/decisions/p4-007-clinician-copilot-ux.md` | No experiments during pilot; guardrails defined |
| P4-008-D | done | `docs/decisions/p4-008-voice-integration.md` | Separate product track; buy STT, <5% medical WER |
| P4-009-D | done | `docs/decisions/p4-009-guideline-corpus.md` | General IM first; editorial board charter defined |
| P4-010-D | done | `docs/decisions/p4-010-causal-inference.md` | DEFER — 5 trust metric thresholds gate activation |
| P4-011-D | done | `docs/decisions/p4-011-adaptive-confidence.md` | Ethics review required; immutable safety floor defined |
| P4-012-D | done | `docs/decisions/p4-012-developer-platform.md` | DEFER — API surface categorized; gated on partner LOI |
| P4-013-D | done | `docs/decisions/p4-013-samd-pathway.md` | Current features NOT SaMD; threshold triggers monitored |
| P4-014-D | done | `docs/decisions/p4-014-data-mesh.md` | PREMATURE — monolith with code boundaries; revisit at 100K |
| P4-015-D | done | `docs/decisions/p4-015-outcome-feedback.md` | Framework defined; direct metrics at pilot launch |
| P4-016-D | done | `docs/decisions/p4-016-trust-proof-center.md` | Evidence model + freshness SLAs defined |
| P4-017-D | done | `docs/decisions/p4-017-mock-surface-removal.md` | Live/Mixed/Simulation labeling standard |
| P4-018-D | done | `docs/decisions/p4-018-demo-workspace.md` | 3 scenarios + reviewer checklist defined |
| P4-019-D | done | `docs/decisions/p4-019-production-reports.md` | 5 report contracts + export metadata schema |
| P4-020-D | done | `docs/decisions/p4-020-evidence-indexed-docs.md` | EvidenceEntry schema + 3-click navigation target |

## Current posture
- Pilot posture as of `2026-02-16`: `conditional_go` (ALL 28 P0 items closed with evidence. Signoff: CONDITIONAL GO with 5 staging conditions. P1: all 35 closed.)
- Staging posture as of `2026-02-16`: `blocked_by_infrastructure` (5 conditions require staging provisioning — no gate marked final GO)
- Broad rollout posture as of `2026-02-16`: `hold` (staging confirmation required for OpenEHR round-trip, Redis failover, Neo4j restore, and cascade simulation)
- P4 execution posture as of `2026-02-17`: `governance_plans_complete` (20/20 Decision ADRs closed; 10/10 I+V closed — 5 sales-readiness P4-016/017/018/019/020 + 5 governance/design P4-006/007/008/009/010; remaining 10 I + 10 V correctly deferred by ADR decision with activation gates defined.)
- Previous: P4 execution posture as of `2026-02-16`: `sales_readiness_complete` (20/20 Decision ADRs closed; 5/5 sales-readiness I+V closed for P4-016/017/018/019/020; remaining 15 I + 15 V correctly deferred by ADR decision with activation gates defined. Final closure sweep PASS 2026-02-16: build 166/166, tests 28/28, all 11 external routes evidence-backed.)
- Previous: P4 posture as of `2026-02-16` (earlier): `partial_implementation`
- Previous: Pilot posture as of `2026-02-16` (earlier): `controlled_go_only`
- Previous: Pilot posture as of `2026-02-13`: `controlled_go_only`
